$4,255 Ans✓✓✓ What annual cost must be exceeded in order for a
patient to be eligible for Medicare Part D in 2020?
advanced expertise / Board Certified Ans✓✓✓ Pharmacists providing
pharmacotherapy consults typically have ________________ and
training in a specific area and may be _______________ in their
specialty
Alzheimer's Disease / Chronic Heart Failure (CHF) / Diabetes /
Dyslipidemia / End Stage Renal Disease (ESRD) / Hypertension /
Respiratory Disease / Bone Disease-Arthritis / Mental Health Diseases
Ans✓✓✓ If targeting specific chronic diseases, Medicare Part D must
include at least five of the following nine core chronic diseases:
Annual CMR with written summaries in CMS standardized format
(Face-to-Face, phone, or telehealth) / Quarterly TMRs with follow-up
interventions when necessary / Interventions for both beneficiaries and
prescribers Ans✓✓✓ What are the required services as part of Medicare
Part D?
Anticoagulation Management Ans✓✓✓ Manage blood thinning agents
based on INR testing via collaborative practice agreements and provide
patient education on self-monitoring/management,
At least quarterly Ans✓✓✓ How often are beneficiaries targeted for
Medicare Part D?
, Automatic ("Opt-out" method of enrollment only) / Ans✓✓✓
Enrollment in Medicare Part D
completed by the patient with the assistance of the pharmacist or by the
pharmacist Ans✓✓✓ Who completes a PML?
comprehensive / targeted Ans✓✓✓ A CMR may be
________________ or __________________.
Comprehensive Medication Review (CMR) Ans✓✓✓ A systematic
process of: Collecting patient-specific information / Assessing
medication therapies to identify drug-related problems / Developing a
prioritized list of drug-related problems / Creating a plan to resolve them
Comprehensive Medication Review (CMR) or Medication Therapy
Review (MTR) / Personal Medication List (PML) / Medication Action
Plan (MAP) / Intervention and/or Referral / Documentation and Follow-
Up Ans✓✓✓ Core elements of an MTM Service model:
Disease Management Coach/Support Ans✓✓✓ Coordinated healthcare
interventions for specific diseases addressing drug and non-drug therapy
with patients' involvement to increase self-management of disease and
medications